SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-014104
Filing Date
2021-04-23
Accepted
2021-04-23 16:06:17
Documents
5
Period of Report
2021-06-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10021759x1_def14a.htm DEF 14A 575495
2 logo_gritstone.jpg GRAPHIC 58026
3 nc10021759x1_pc01.jpg GRAPHIC 573410
4 nc10021759x1_pc02.jpg GRAPHIC 414958
5 sig_andrewallenmd.jpg GRAPHIC 15068
  Complete submission text file 0001140361-21-014104.txt   2037463
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone Oncology, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38663 | Film No.: 21849750
SIC: 2836 Biological Products, (No Diagnostic Substances)